Come up with a name for your new list and we'll add to it:
Traxxsson raised a round of funding on December 16, 2010. Investors include
St. Louis Arch Angels.
Traxxsson is developing molecular tests to diagnose and track diseases after diagnosis. These assays are targeted to allow clinicians to tailor therapeutics for each patient, and monitor treatment f…